SciSparc Ltd. Acquires MitoCareX Bio Ltd.

Ticker: SPRC · Form: 6-K · Filed: Mar 3, 2025 · CIK: 1611746

Scisparc Ltd. 6-K Filing Summary
FieldDetail
CompanyScisparc Ltd. (SPRC)
Form Type6-K
Filed DateMar 3, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: acquisition, merger, biotech

TL;DR

SciSparc is buying MitoCareX Bio Ltd. - deal closed Feb 25, 2025.

AI Summary

On February 25, 2025, SciSparc Ltd. entered into a Securities Purchase and Exchange Agreement with MitoCareX Bio Ltd. This agreement involves the acquisition of MitoCareX by SciSparc. The filing does not specify any dollar amounts or further details regarding the transaction's financial implications.

Why It Matters

This acquisition could significantly alter SciSparc's business focus and market position, depending on the strategic integration of MitoCareX's operations and intellectual property.

Risk Assessment

Risk Level: medium — The acquisition of a private company introduces integration risks and potential uncertainties regarding the valuation and future performance of the acquired entity.

Key Players & Entities

  • SciSparc Ltd. (company) — Acquiring company
  • MitoCareX Bio Ltd. (company) — Acquired company
  • February 25, 2025 (date) — Date of agreement

FAQ

What is the nature of the Securities Purchase and Exchange Agreement between SciSparc Ltd. and MitoCareX Bio Ltd.?

The agreement, entered into on February 25, 2025, is for the acquisition of MitoCareX Bio Ltd. by SciSparc Ltd.

When was the agreement between SciSparc Ltd. and MitoCareX Bio Ltd. finalized?

The agreement was entered into on February 25, 2025.

Is MitoCareX Bio Ltd. a public or private company?

MitoCareX Bio Ltd. is a private company incorporated under the laws of the State of Israel.

What is the principal executive office address for SciSparc Ltd.?

The principal executive offices of SciSparc Ltd. are located at 20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916, Israel.

Does SciSparc Ltd. file its annual reports under Form 20-F or Form 40-F?

SciSparc Ltd. files its annual reports under cover of Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on March 3, 2025 regarding SciSparc Ltd. (SPRC).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.